methylmalonic acid has been researched along with Drug Refractory Epilepsy in 1 studies
Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F | 1 |
| Liang, L | 1 |
| Ling, S | 1 |
| Yu, Y | 1 |
| Chen, T | 1 |
| Xu, F | 1 |
| Gong, Z | 1 |
| Han, L | 1 |
1 other study available for methylmalonic acid and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Clinical characteristics and genotype analysis of five infants with cblX type of methylmalonic acidemia.
Topics: Acetylcarnitine; Amino Acid Metabolism, Inborn Errors; China; Drug Resistant Epilepsy; Female; Genot | 2022 |